Bio-Rad’s SARS-CoV-2 Serology Test Granted EUA
Clinical evaluation of Bio-Rad’s SARS-CoV-2 total antibody test has demonstrated diagnostic specificity of more than 99% and sensitivity of 98%.
Read MorePosted by | May 4, 2020 | Covid 19, Emerging & Zoonotic Diseases, Hematology & Serology, Infectious Diseases, Serology Instrumentation |
Clinical evaluation of Bio-Rad’s SARS-CoV-2 total antibody test has demonstrated diagnostic specificity of more than 99% and sensitivity of 98%.
Read MorePosted by | Apr 22, 2020 | Covid 19, Emerging & Zoonotic Diseases, Hematology & Serology, Infectious Diseases, Serology Instrumentation |
The Elecsys Anti-SARS-CoV-2 serology test will support the detection of antibodies against SARS-CoV-2 in patients who have been exposed to the virus.
Read MorePosted by | Apr 22, 2020 | Allergy & Autoimmune, Covid 19, Emerging & Zoonotic Diseases, Hematology & Serology, Infectious Diseases, Serology Instrumentation |
The question of when we can return to work and resume our normal activities is one of the most critical issues facing our nation.
Read MorePosted by | Apr 14, 2020 | Coagulation Testing, Hematology & Serology, Hematology Instrumentation, POC Instruments, POC Rapid Assays, POC Reagents & Test Kits, Point-of-Care |
The Allegro and its StatStrip-A companion meter now provide 18 tests to help physicians make therapeutic decisions and adjustments at the point of care.
Read MorePosted by | Apr 10, 2020 | Blood Banking, Covid 19, Emerging & Zoonotic Diseases, Hematology & Serology, Infectious Diseases |
Based on recently completed studies and epidemiologic data, FDA has concluded that current policies regarding certain donor eligibility criteria can be modified without compromising the safety of the blood supply.
Read More